Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13DFiled 34 h ago

Medicus Pharma Ltd.: Bokhari Raza amends Schedule 13D stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13D, sec.gov, 17 November 2026, by SEC EDGAR SCHEDULE 13D

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Bokhari Raza filed an amended Schedule 13D with the SEC (accession 0000950142-26-003112) updating his stake in Medicus Pharma Ltd. The amendment revises Raza's previously reported beneficial ownership position in the pharmaceutical company. Schedule 13D filings are required when an investor holds more than 5% of a company's voting shares and intends to influence control, making the update a signal of potential shifts in ownership or intent. The filing did not disclose a change in the size of the stake in the headline. Investors should watch for further 13D amendments or related Form 4 insider filings to gauge whether Raza is accumulating or reducing his position.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13D's report. It can get details wrong, so check the source.

Named in this story

Bokhari Raza, Medicus Pharma Ltd.